[adinserter block="3"]
[adinserter block="3"]
News

Alpine Immune Sciences Announces Initiation of Dosing in 240 mg IgA Nephropathy Cohort of Povetacicept Clinical Study (RUBY-3)

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the successful initiation of the second IgA nephropathy (IgAN) dose cohort in […]

News

Exclusive: 10x Genomics CEO touts ‘incredible traction’ with newest launch, shipping over 100 spatial biology analyzers

10x Genomics has seen “incredible traction” with its newest product, Xenium, shipping over 100 analyzers since launching less than a year ago, CEO Serge Saxonov told Endpoints News. The milestone, announced Tuesday, is the latest […]

[adinserter block="3"]